Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
X4 Pharmaceuticals Prices $65 Million Public Offering of Common Stock and Class B Warrants
-
Net Asset Value(s)
-
Director Declaration: Additional Directorship
-
ChemoCentryx (CCXI) PT Raised to $48 at Canaccord Genuity
-
Form 8.3 - Accesso Technology Group plc
-
X4 Pharmaceuticals (XFOR) to Offer Common Stock and Warrants
-
X4 Pharmaceuticals Announces Proposed Public Offering
-
Canaccord Genuity Reiterates Buy Rating on Detour Gold Corp. (DGC:CN) (DRGDF)
-
Canaccord Genuity Reiterates Buy Rating on Alimentation Couche-Tard Inc (ATD/B:CN) (ANCUF)
-
Royal Gold (RGLD) PT Lowered to $125 at Canaccord Genuity
-
Osisko Gold Royalties Ltd. (OR:CN) (OR) PT Lowered to Cdn$18 at Canaccord Genuity
-
Altius Minerals Corp (ALS:CN) (ATUSF) PT Lowered to Cdn$17.50 at Canaccord Genuity
-
Transaction in Own Shares
-
Harpoon Therapeutics (HARP) PT Raised to $26 at Canaccord Genuity
-
Canaccord Genuity Reiterates Hold Rating on Titan Mining Corp. (TI:CN) (TNMCF)
-
AMEX Announces Partial Exercise of Underwriter’s Option for Additional Gross Proceeds of $981,900 and Aggregate Gross Proceeds of $8,982,000
-
Discovery 2019 Short Duration LP Closes IPO
-
Canaccord Genuity Reiterates Buy Rating on Cree (CREE) Following Analyst Day
-
Form 8.3 - Accesso Technology Group plc
-
Atalaya Mining PLC Announces Third Quarter Financial Results
-
Canaccord Genuity Reiterates Buy Rating on Docebo Inc. (DCBO:CN)
-
Net Asset Value(s)
-
Canaccord Genuity Reiterates Spec. Buy Rating on PetroShale (PSH:CN) (PSHIF)
-
BTIG Announces Expansion of Equity Research Division with Consumer Lifestyle and Wellness Brands Analyst Camilo Lyon
-
Form 8.3 - Accesso Technology Group plc
-
CRISPR Therapeutics (CRSP) PT Raised to $80 at Canaccord Genuity
-
MAXIMUS, Inc. (MMS) PT Lowered to $76 at Canaccord Genuity
-
Regulus Resources (REG:CN) (RGLSF) PT Raised to Cdn$2.75 at Canaccord Genuity
-
Canaccord Genuity Reiterates Buy Rating on Corus Entertainment (CJR/B:CN) (CJREF)
-
binx health To Present At The Canaccord Genuity Medical Technology And Diagnostics Forum
-
Orchestra BioMed™ to Present at the Canaccord Genuity MedTech and Diagnostics Forum and the 31st Annual Piper Jaffray Healthcare Conference
-
Form 8.3 - Accesso Technology Group plc
-
iCAD to Participate at the Cannacord Genuity Medtech & Diagnostics Forum
-
MedMen Announces Layoffs and Overall Plan to Achieve Positive EBITDA
-
T2 Biosystems to Present at the 13th Annual Canaccord Genuity Medical Technology & Diagnostics Forum
-
Form 8.3 - Accesso Technology Group plc
-
Shockwave Medical (SWAV) Prices 2.48M Share Common Offering at $36.25/Sh
-
Shockwave Announces Pricing of Public Offering of Common Stock
-
Shockwave Announces Pricing of Public Offering of Common Stock
-
Middlefield Global Real Asset Fund Announces Exchange Ratios
-
Chembio Diagnostics to Participate in Upcoming Investor Conferences
-
Youth INC Celebrates 25 Years of Impact Raising Over $3M for New York City Kids
-
H2O Innovation Completes $22 M Equity Offering
-
Obalon To Present at Two Upcoming Institutional Investor Conferences
-
SetPoint Medical to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum 2019
-
Obalon To Present at Two Upcoming Institutional Investor Conferences
-
STRATA Skin Sciences to Participate in the 13th Annual Canaccord Genuity Medical Technologies & Diagnostics Forum
-
Avante Logixx Secures up to $18.0 million in Financing from Well Known Canadian Investor and To Expand Nationally with Acquisition of A.S.A.P. Secured Inc.
-
Form 8.3 - Accesso Technology Group plc
-
Starlight Hybrid Global Real Assets Trust Announces Private Placement

